Touting new way of mining neuro targets, Takeda spinout draws $45M from GV, Bill Gates, Foresite
More than three years after Takeda spun out its top neuroscience team in Cambridge, UK into a transatlantic biotech, GV, Bill Gates and Foresite …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
